Lenz Robert A. sold NBP
August 22, 2026 · Form 4 insider transaction
Lenz Robert A. sold 7,486 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,486
Price
$0.00
Total value
N/A
InsiderLenz Robert A.
RoleOfficer, Director
CompanyNovaBridge Biosciences (NBP)
SecurityRestricted Share Units
Transaction codeM: Option exercise
Transaction dateAugust 22, 2026
Filing dateAugust 25, 2026
Shares owned after14,974
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.; Reported securities represent ADSs.; On August 22, 2025, the Reporting Person was granted 22,460 restricted share units ("RSUs"). The RSUs vested or shall vest over three years in three equal annual installments on August 22, 2026, 2027 and 2028.